Fox Chase Cancer Center Welcomes Dr. Michael Seidman

seidman
Michael Seidman, MD, has joined Fox Chase Cancer Center as a Professor in the Department of Hematology/Oncology.

PHILADELPHIA (August 8, 2024) — Fox Chase Cancer Center is pleased to announce the hiring of Michael Seidman, MD, as a Professor in the Department of Hematology/Oncology

Seidman is joining Fox Chase after spending over 15 years at Alliance Cancer Specialists in Horsham, Pennsylvania, where he provided care to patients with a wide array of hematologic and oncologic disorders, assisted in the development of a new radiation oncology center, and participated in clinical trials. He also served as a board member of Alliance Cancer Specialists and managing partner of the Abington Division. 

He was also on the medical staff of Chestnut Hill Hospital, Holy Redeemer Medical Center, and Jefferson Abington Hospital. Seidman also served on the Cancer Committee for Holy Redeemer and Jefferson Abington, where he was a member of the Medical Executive Committee. He has been listed as a Top Doctor in oncology by Philadelphia magazine from 2020 through 2023. 

Seidman received his medical degree from the Lewis Katz School of Medicine at Temple University. He completed an internal medicine residency at Temple University Hospital, followed by an oncology fellowship at New York University Medical Center. While at NYU, he was named Hematology/Oncology Chief Fellow and Oncology Fellow of the Year. 

Seidman has a number of professional publications and presentations to his credit, and some of his presentations were delivered in Barcelona at the First World Meeting of Interdisciplinary Melanoma Centers. He is board certified in hematology and medical oncology. 

Seidman began his tenure at Fox Chase on August 4, 2024.

Fox Chase Cancer Center (Fox Chase), which includes the Institute for Cancer Research and the American Oncologic Hospital and is a part of Temple Health, is one of the leading comprehensive cancer centers in the United States. Founded in 1904 in Philadelphia as one of the nation’s first cancer hospitals, Fox Chase was also among the first institutions to be designated a National Cancer Institute Comprehensive Cancer Center in 1974. Fox Chase is also one of just 10 members of the Alliance of Dedicated Cancer Centers. Fox Chase researchers have won the highest awards in their fields, including two Nobel Prizes. Fox Chase physicians are also routinely recognized in national rankings, and the Center’s nursing program has received the Magnet recognition for excellence six consecutive times. Today, Fox Chase conducts a broad array of nationally competitive basic, translational, and clinical research, with special programs in cancer prevention, detection, survivorship, and community outreach. It is the policy of Fox Chase Cancer Center that there shall be no exclusion from, or participation in, and no one denied the benefits of, the delivery of quality medical care on the basis of race, ethnicity, religion, sexual orientation, gender, gender identity/expression, disability, age, ancestry, color, national origin, physical ability, level of education, or source of payment.

For more information, call 888-369-2427